Clinical Trial Update: Hyper-CVAD Treatment of Adult T-cell Acute Lymphoblastic Leukemia in Sweden.

View source ↗

Summary

A completed clinical trial in Sweden evaluated the Hyper-CVAD chemotherapy regimen for adults with T-cell acute lymphoblastic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• Hyper-CVAD

Snippet

Sponsor: Region Örebro County | Conditions: T-cell Acute Lymphoblastic Leukemia | Status: COMPLETED